Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Lilly BrasilLilly Brasil
VS
Glenmark PharmaceuticalsGlenmark Pharmaceuticals
Lilly Brasil

Lilly Brasil

Av. Morumbi, 8264, São Paulo, BR

Last Update: 02/02/2026

View Profile
Between 750 and 799
https://www.lilly.com.br
761/1000Fair

A Lilly é líder mundial em saúde e há mais de um século une cuidado com descoberta para melhorar a vida de pessoas ao redor do mundo. A excelência, a integridade e o respeito pelas pessoas são valores inegociáveis e nos guiam em tudo o que fazemos. Nosso time de profi...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:21
12-month incidents
0
Known data breaches
0
Attack type number
0
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 29/04/2026

View Profile
639/1000Poor

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,777
Subsidiaries:0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
Lilly Brasil

Lilly Brasil

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Lilly Brasil in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 3.85% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Lilly Brasil (X = Date, Y = Severity)

Lilly Brasil cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Lilly Brasil

Lilly Brasil

Incidents
No explicit notable incidents reported.
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Incidents
🔒 Incident : Ransomware
KOPGLE1777473227

FAQ

Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?
Between Lilly Brasil company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?
Between Lilly Brasil and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Lilly Brasil and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Lilly Brasil or Glenmark Pharmaceuticals ?
Which company is PCI DSS compliant - Lilly Brasil or Glenmark Pharmaceuticals ?
Between Lilly Brasil and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Lilly Brasil and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-50044
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-44955
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-42933
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 10.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.9
CVE-2026-40430
SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-28698
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 8.6)
CVSS3
Base Score: 8.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 9.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
3.9